| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0053c25f3331ddbc91dd14c908da1843 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-84 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-227
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1875
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00 |
| filingDate |
1994-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d29841b52e2476ed0e98c6048ae89979
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_185cc8de20ea737f74190c02d563cbba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc42dc94c1a611287f8177791b028fd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3515d0021759a05776817eb41331827f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93325fcf2474ada75f9734fe8887afc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce933e39f17ab63e9326810bfd63c65a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e78873574937e34bb28a4e3d4ac7cd98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b686df7c58e0973301e0b7bb104e5ee2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad00e6ce25a9b31fde2a78b4c0029b4f |
| publicationDate |
1996-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0724459-A1 |
| titleOfInvention |
Formulations for delivery of osteogenic proteins |
| abstract |
A composition is disclosed comprising a pharmaceutically acceptable admixture of an osteogenic protein; a porous particulate polymer matrix; an osteogenic protein-sequestering amount of blood clot; and a calcium sulfate hemihydrate-containing substance. Also disclosed are formulations of bone morphogenetic proteins with improved solubility and/or stability characteristics. |
| priorityDate |
1993-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |